Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
about
Antibiotics for treating community acquired pneumonia in people with sickle cell diseaseAntibiotics for treating community acquired pneumonia in people with sickle cell diseaseThe global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.High levels of placenta growth factor in sickle cell disease promote pulmonary hypertensionHealth-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium.Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.Sickle cell disease and venous thromboembolism.Non-congenital heart disease associated pediatric pulmonary arterial hypertensionSickle cell disease: old discoveries, new concepts, and future promise.Sildenafil in the treatment of pulmonary hypertension.Investigational agents for sickle cell disease.Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problemRelationship between pulmonary and cardiac abnormalities in sickle cell disease: implications for the management of patients.Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell diseaseElevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.Symptomatic pulmonary hypertension in a child with sickle cell disease.N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in sickle cell disease: relation to vasculopathy and disease severity.Correlates of Pulmonary Function in Children with Sickle Cell Disease and Elevated Fetal Hemoglobin.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
P2860
Q24197977-398CDA88-3150-4F92-9F1F-4489E6B0507FQ24245077-723130D4-108F-41F4-8A7C-1592F30FEB84Q30250302-6AB64242-4ABB-4A34-ADAC-33FA8B0D67AFQ33899415-D9D1904F-BEEB-4A3A-9509-DFE31D1F26BAQ33997180-AF3DDFCA-96F0-4A63-B75A-E67B12E7BE4FQ34026575-59ED80D7-AC89-435D-A9ED-0EDF66C7D470Q34579250-6D30B00F-218E-4D64-BFE8-96A471B3467BQ34846466-92E62B69-1861-4131-B09D-EADBE1C3086FQ35039996-9B46604D-8FA9-47EA-BCFD-D788208B468AQ35165691-71AD0733-8841-4D79-9CAA-E8F88D469A51Q35723452-FE22608F-0722-42E6-AB27-294E647E8FF8Q36013070-EE54B4DD-98C3-46AD-BA75-7EAFF15EBB3AQ36543049-BD51F89D-185D-44AC-A1D4-DCE1083C0DA7Q36673817-E53115CC-A3F3-42AE-B955-897E89B3B126Q36674858-6F0191B9-CA6F-4633-AF45-3B81112698E5Q37082000-AAF7F8AA-BCFB-4CF2-BE32-2A72D9E64DA9Q37112890-0BC5B6C0-4C50-4C4E-9363-0FF7DA72E1B7Q37944597-6E151601-85F5-4FC4-9488-FBDD1031EAC5Q39007637-8B7C4198-ADBE-4DF2-93C6-ADE875E99018Q39589473-5BE7473F-CF5F-45C6-A208-3B960B0C6A18Q41592113-E4F75E62-2A87-45BA-A1B6-863B797C593DQ42783868-6CD8C288-09DB-499B-A50A-920E1FC155BFQ43180474-51C00AB8-9912-475A-A1C5-F4FAE4309429Q46344026-28889619-799C-42A1-96B9-3A5060FBEC74Q46507101-248B2CFF-95BF-4164-B535-A5219E21F054Q49572482-031311AF-9FD3-4E15-8818-FA70835A1D01Q55427971-7E4AA26E-CA30-4A9F-98CF-B2381CFE4DE3
P2860
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@ast
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@en
type
label
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@ast
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@en
prefLabel
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@ast
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@en
P1476
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.
@en
P2093
Oswaldo Castro
P304
881-96, vii
P356
10.1016/J.HOC.2005.07.007
P577
2005-10-01T00:00:00Z